眉间皱纹的临床试验
总计10000个结果
-
City of Hope Medical CenterNational Cancer Institute (NCI)尚未招聘解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 转移性激素受体阳性乳腺癌 | 不可切除的激素受体阳性乳腺癌 | Advanced Hormone Receptor-Positive Breast Carcinoma美国
-
Margaret Gatti-Mays招聘中解剖学 IV 期乳腺癌 AJCC v8 | HER2-阴性乳腺癌美国
-
Adrienne G. WaksEli Lilly and Company; Verastem, Inc.招聘中
-
University of MalayaPfizer; Cancer Research Malaysia; Pantai Hospital Kuala Lumpur; Hospital Sultan Ismail招聘中
-
Jonsson Comprehensive Cancer Center完全的关节痛 | 解剖学 I 期乳腺癌 AJCC v8 | 解剖学 IA 期乳腺癌 AJCC v8 | 解剖学 IB 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 IIA 期乳腺癌 AJCC v8 | 解剖学 IIB 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 预后 I 期乳腺癌 AJCC v8 | 预后 IA 期乳腺癌 AJCC v8 | 预后 IB 期乳腺癌 AJCC v8 | 预后 II 期乳腺癌 AJCC v8 | 预后 IIA 期乳腺癌 AJCC v8 | 预后 IIB 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 绝经后美国
-
University of ArizonaNational Cancer Institute (NCI)完全的超重 | 解剖学 I 期乳腺癌 AJCC v8 | 解剖学 IA 期乳腺癌 AJCC v8 | 解剖学 IB 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 IIA 期乳腺癌 AJCC v8 | 解剖学 IIB 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 预后 I 期乳腺癌 AJCC v8 | 预后 IA 期乳腺癌 AJCC v8 | 预后 IB 期乳腺癌 AJCC v8 | 预后 II 期乳腺癌 AJCC v8 | 预后 IIA 期乳腺癌 AJCC v8 | 预后 IIB 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 癌症幸存者 | 绝经后美国
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)暂停解剖学 IIA 期乳腺癌 AJCC v8 | 0 期乳腺癌解剖学 AJCC v8 | HER2-阴性乳腺癌 | 解剖学 1 期乳腺癌 AJCC v8 | 雌激素受体阳性乳腺癌美国, 波多黎各
-
Mayo ClinicNational Cancer Institute (NCI)完全的I 期乳腺癌 AJCC v7 | IA 期乳腺癌 AJCC v7 | IB 期乳腺癌 AJCC v7 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | IIIA 期乳腺癌 AJCC v7美国
-
National Cancer Institute (NCI)完全的IV 期乳腺癌 | 复发性乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阴性 | HER2/Neu 阴性 | 孕激素受体阴性 | 三阴性乳腺癌 | 男性乳腺癌 | 成人实体瘤美国
-
Jonsson Comprehensive Cancer CenterFaxitron bioptics, LLC完全的I 期乳腺癌 AJCC v7 | IA 期乳腺癌 AJCC v7 | IB 期乳腺癌 AJCC v7 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | 0 期乳腺癌 AJCC v6 和 v7 | 腋窝淋巴结阳性美国
-
Massachusetts General HospitalNational Cancer Institute (NCI); American Society of Clinical Oncology主动，不招人
-
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.主动，不招人
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)主动，不招人
-
Institut Claudius Regaud完全的无淋巴结受累且 < 或 = 30 mm 的三阴性乳腺癌法国
-
City of Hope Medical CenterNational Cancer Institute (NCI); Biopharmaceutical Research Company招聘中解剖学 I 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 0 期乳腺癌解剖学 AJCC v8 | 乳腺导管原位癌 | 乳腺癌 | 雌激素受体阳性乳腺癌 | 孕酮受体阳性乳腺癌美国
-
Northwestern UniversityNational Cancer Institute (NCI)终止疼痛 | 周围神经病变 | IV 期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | 化疗药物毒性 | 治疗相关毒性美国
-
Jonsson Comprehensive Cancer Center完全的癌症幸存者 | I 期乳腺癌 AJCC v7 | IA 期乳腺癌 AJCC v7 | IB 期乳腺癌 AJCC v7 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | IIIA 期乳腺癌 AJCC v7 | 0 期乳腺癌 AJCC v6 和 v7美国
-
Yuan YuanOsel, Inc.; Miyarisan Pharmaceuticals, Co., Ltd.尚未招聘
-
Jiangsu Alphamab Biopharmaceuticals Co., Ltd招聘中
-
West German Study GroupMerck Sharp & Dohme LLC; Gilead Sciences招聘中
-
Fundacio Clinic BarcelonaRoche Pharma AG; SOLTI Breast Cancer Research Group终止
-
Yale UniversityNational Cancer Institute (NCI)完全的
-
Ziauddin UniversityJinnah Sindh Medical University完全的
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.主动，不招人乳腺癌 | 新辅助治疗 | 激素受体阳性乳腺癌 | HER2低表达乳腺癌中国
-
Institut Cancerologie de l'OuestSIRIC ILIAD完全的
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI)完全的
-
Borstkanker Onderzoek GroepRoche Pharma AG; Teva Pharma完全的
-
Sun Yat-sen University招聘中
-
Center Eugene Marquis尚未招聘
-
Fondazione del Piemonte per l'Oncologia招聘中
-
Xijing HospitalQilu Pharmaceutical Co., Ltd.招聘中